Article
A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
Pharmacogenetics and genomics - 1 Dec 2008
Donnelly Louise A, Doney Alex S F, Dannfald Jennifer, Whitley Adrian L, Lang Chim C, Morris Andrew D, Donnan Peter T, Palmer Colin N A
Abstract excerpt
BACKGROUND: Considerable interindividual variation exists in cholesterol-lowering response to 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors (statins). HMGCR catalyzes the rate-limiting step in cholesterol biosynthesis, and also plays a significant role in cholesterol homeostasis. We evaluated the association of a single nucleotide polymorphism (rs17238540) in the HMGCR gene with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
